Marchetti A - Search Results

1

Pharmacotherapies for attention-deficit/hyperactivity disorder: expected-cost analysis.

Marchetti A, Magar R, Lau H, Murphy EL, Jensen PS, Conners CK, Findling R, Wineburg E, Carotenuto I, Einarson TR, Iskedjian M. Marchetti A, et al. Clin Ther. 2001 Nov;23(11):1904-21. doi: 10.1016/s0149-2918(00)89086-4. Clin Ther. 2001. PMID: 11768842

2

Impact of palivizumab on expected costs of respiratory syncytial virus infection in preterm infants: potential for savings.

Marchetti A, Lau H, Magar R, Wang L, Devercelli G. Marchetti A, et al. Clin Ther. 1999 Apr;21(4):752-66. doi: 10.1016/S0149-2918(00)88326-5. Clin Ther. 1999. PMID: 10363740

3

Management of patients with Bacilli Calmette-Guérin-refractory carcinoma in situ of the urinary bladder: cost implications of a clinical trial for valrubicin.

Marchetti A, Wang L, Magar R, Grossman HB, Lamm DL, Schellhammer PF, Erwin-Toth P. Marchetti A, et al. Clin Ther. 2000 Apr;22(4):422-38. doi: 10.1016/s0149-2918(00)89011-6. Clin Ther. 2000. PMID: 10823364 Clinical Trial.

4

Duration of effect of botulinum toxin type A in adult patients with cervical dystonia: a retrospective chart review.

Brashear A, Watts MW, Marchetti A, Magar R, Lau H, Wang L. Brashear A, et al. Among authors: marchetti a. Clin Ther. 2000 Dec;22(12):1516-24. doi: 10.1016/s0149-2918(00)83049-0. Clin Ther. 2000. PMID: 11192142

5

Clinical and economic impact of new trends in glaucoma treatment.

Marchetti A, Magar R, An P, Nichol M. Marchetti A, et al. MedGenMed. 2001 Jul 26;3(4):6. MedGenMed. 2001. PMID: 11549985 Clinical Trial.

6

A pharmacoeconomic evaluation of intravenous fosphenytoin (Cerebyx) versus intravenous phenytoin (Dilantin) in hospital emergency departments.

Marchetti A, Magar R, Fischer J, Sloan E, Fischer P. Marchetti A, et al. Clin Ther. 1996 Sep-Oct;18(5):953-66. doi: 10.1016/s0149-2918(96)80051-8. Clin Ther. 1996. PMID: 8930434 Clinical Trial.

7

Effects of pioglitazone and rosiglitazone on blood lipid levels and glycemic control in patients with type 2 diabetes mellitus: a retrospective review of randomly selected medical records.

Boyle PJ, King AB, Olansky L, Marchetti A, Lau H, Magar R, Martin J. Boyle PJ, et al. Among authors: marchetti a. Clin Ther. 2002 Mar;24(3):378-96. doi: 10.1016/s0149-2918(02)85040-8. Clin Ther. 2002. PMID: 11952022

8

Multicenter retrospective assessment of thiazolidinedione monotherapy and combination therapy in patients with type 2 diabetes: comparative subgroup analyses of glycemic control and blood lipid levels.

Olansky L, Marchetti A, Lau H. Olansky L, et al. Among authors: marchetti a. Clin Ther. 2003;25 Suppl B:B64-80. doi: 10.1016/s0149-2918(03)80243-6. Clin Ther. 2003. PMID: 14553867 Review.

9

A pharmacoeconomic analysis of topical therapies for patients with mild-to-moderate stable plaque psoriasis: a US study.

Marchetti A, LaPensee K, An P. Marchetti A, et al. Clin Ther. 1998 Jul-Aug;20(4):851-69. doi: 10.1016/s0149-2918(98)80146-x. Clin Ther. 1998. PMID: 9737842

10

Retrospective evaluation of the dose of Dysport and BOTOX in the management of cervical dystonia and blepharospasm: the REAL DOSE study.

Marchetti A, Magar R, Findley L, Larsen JP, Pirtosek Z, Růzicka E, Jech R, Sławek J, Ahmed F. Marchetti A, et al. Mov Disord. 2005 Aug;20(8):937-44. doi: 10.1002/mds.20468. Mov Disord. 2005. PMID: 15810022 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

759 results

Search Page

Filters